X2S Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sinopharm Group Co Ltd

Watchlist Manager

Watchlist

Price: 1.906 EUR -0.29% Market Closed

Market Cap: €2.6B

S	Sinopharm Group Co Ltd XMUN:X2S	CN
C	Cenovus Energy Inc F:CXD	CA
O	O'Reilly Automotive Inc XMUN:OM6	US
E	EDP Renovaveis SA DUS:EDW	ES
C	CA Sales Holdings Ltd JSE:CAA	ZA
	Mandatum Oyj F:N2S	FI

Profitability Summary

Sinopharm Group Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Declining Gross Margin

8% > 7%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 3%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

2% > 2%

Low ROE

Positive 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.